Inspire Medical Systems Free Cash Flow 2017-2024 | INSP

Inspire Medical Systems free cash flow from 2017 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Inspire Medical Systems Annual Free Cash Flow
2023 1.02
2022 2.47
2021 -24.79
2020 -55.50
2019 -35.59
2018 -18.94
2017 -16.20
2016 -18.26
Inspire Medical Systems Quarterly Free Cash Flow
2024-03-31 -2.84
2023-12-31 1.02
2023-09-30 -8.21
2023-06-30 -4.86
2023-03-31 -5.10
2022-12-31 2.47
2022-09-30 -13.85
2022-06-30 -21.34
2022-03-31 -13.96
2021-12-31 -24.79
2021-09-30 -24.99
2021-06-30 -23.50
2021-03-31 -11.72
2020-12-31 -55.50
2020-09-30 -50.79
2020-06-30 -40.66
2020-03-31 -15.03
2019-12-31 -35.59
2019-09-30 -29.07
2019-06-30 -25.06
2019-03-31 -11.22
2018-12-31 -18.94
2018-09-30 -16.16
2018-06-30 -12.61
2018-03-31 -6.43
2017-12-31 -16.20
2017-09-30 -12.86
2017-06-30 -9.61
2017-03-31 -5.57
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.855B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.024B 20.33
Axonics (AXNX) United States $3.435B 0.00
IRhythm Technologies (IRTC) United States $3.072B 0.00
10x Genomics (TXG) United States $3.022B 0.00
Azenta (AZTA) United States $3.015B 163.85
Olink Holding AB (publ) (OLK) Sweden $2.918B 0.00
Enovis (ENOV) United States $2.779B 20.60
Hims & Hers Health (HIMS) United States $2.603B 0.00
Privia Health (PRVA) United States $2.238B 99.26
Schrodinger (SDGR) United States $1.679B 0.00
Omnicell (OMCL) United States $1.376B 47.56
Phreesia (PHR) United States $1.237B 0.00
Standard BioTools (LAB) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Talkspace (TALK) United States $0.451B 0.00
Clover Health Investments (CLOV) United States $0.431B 0.00
Health Catalyst (HCAT) United States $0.393B 0.00
Pulmonx (LUNG) United States $0.342B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.300B 0.00
P3 Health Partners (PIII) United States $0.236B 0.00
Outset Medical (OM) United States $0.214B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
American Well (AMWL) United States $0.150B 0.00
Augmedix (AUGX) United States $0.128B 0.00
TruBridge (TBRG) United States $0.121B 5.17
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.094B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.049B 0.00
Movano (MOVE) United States $0.039B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.017B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.012B 0.00
Biotricity (BTCY) United States $0.011B 0.00
ETAO (ETAO) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00